Results 51 to 60 of about 49,037 (222)
Mechanism of natural rifampin resistance of Streptomyces spp. [PDF]
, 2005 In a previous phylogenetic study of the genus Streptomyces using the rpoB gene, N531, which stands for an aspargine residue in position 531 of RpoB instead of serine (S531), known to be associated with natural rifampin resistance in several organisms ...
H Kim +9 more
core +1 more source
Outcome of BCG Vaccination in ADA-SCID Patients: A 12-Patient Series
Biomedicines, 2023 Vaccination with Bacillus Calmette–Guérin (BCG) can be harmful to patients with combined primary immunodeficiencies. We report the outcome of BCG vaccination in a series of twelve patients affected by adenosine deaminase deficiency (ADA-SCID).
Daniele Canarutto +22 more
doaj +1 more source
Diagnosis of bacteraemia in neonatal foals using 16S rRNA high‐throughput sequencing
Equine Veterinary Journal, EarlyView.Abstract Background Sepsis is an important cause of morbidity and mortality in foals. Early diagnosis can improve outcome but is complicated by non‐specific clinical signs and delayed confirmation of infection via blood culture. Molecular assays represent a rapid and more sensitive alternative.
Flavie Payette +7 more
wiley +1 more source
Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin [PDF]
, 1992 We examined the effect of azithromycin (CP-62,993), a new oral macrolide-like antibiotic, alone and in combination with rifampin, as treatment for experimental staphylococcal osteomyelitis. Clindamycin was used as a comparison drug.
Sande, E +5 more
core +1 more source
BMC Medicine, 2009 Background Rifampin is a key drug in antituberculosis chemotherapy because it rapidly kills the majority of bacilli in tuberculosis lesions, prevents relapse and thus enables 6-month short-course chemotherapy.
McIlleron Helen +8 more
doaj +1 more source
Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis [PDF]
, 2018 Yu-Tsung Huang,1–3 Chun-Hsing Liao,1,4 Shey-Ying Chen,5 Chia-Jui Yang,1,4 Hsin-Sui Hsu,1 Lee-Jene Teng,2,3 Po-Ren Hsueh2,6 1Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan; 2Department of Laboratory Medicine,
Hsueh PR +6 more
core
Regulation of MicroRNA Expression by Rifampin in Human Hepatocytes [PDF]
, 2013 Rifampin causes drug interactions by altering hepatic drug metabolism. Because microRNAs (miRNAs) have been shown to regulate genes involved in drug metabolism, we determined the effect of rifampin on the expression of hepatic miRNAs.
Philips, Santosh +9 more
core +1 more source
Rifampin-Associated Thrombocytopenia Secondary to Poor Compliance [PDF]
, 1989 Rifampin can be associated with severe adverse effects such as hepatitis, acute renal failure, hemolytic anemia, and thrombocytopenia. Thrombocytopenia has traditionally been associated with intermittent therapy.
Vu Hoang +3 more
core +1 more source
Emerging Infectious Diseases, 2016 Few studies have examined whether the Xpert MTB/RIF test improves time to treatment initiation for persons with multidrug-resistant tuberculosis (MDR TB). We determined the impact of this test in Latvia, where it was introduced in 2010. After descriptive
Helen R. Stagg +9 more
doaj +1 more source
Microbiology Spectrum, 2023 The increasing occurrence of extensively drug-resistant and pan-drug-resistant K. pneumoniae has posed a serious threat to global public health. Therefore, new antimicrobial strategies are urgently needed to combat these resistant K.
Pengfei She +7 more
doaj +1 more source